Skip to main content

Table 1 Patients’ Demographics, and Presentation, Lesion Characteristics and Risk Factors of DVT

From: Rheolytic thrombectomy using an AngioJet ZelanteDVT catheter or a Solent Omni catheter for patients with proximal vein thrombosis

Characteristic

ZelanteDVT Group (n = 17)

Solent Group (n = 23)

Age, years, mean ± SD

55.4 ± 21.5

60.4 ± 15.4

Female, sex, n (%)

10 (58.8)

16 (69.6)

Onset of Symptoms at Presentation, n (%)

  ≤ 7 days

11 (64.7)

16 (69.6)

  ≥ 7 days and ≤ 14 days

6 (35.3)

7 (30.4)

Thrombus Segment

 Isolated iliofemoral DVT

11 (64.7)

15 (65.2)

 With popliteal/calf DVT

6 (35.3)

8 (34.8)

Thrombus Limbs

 Left

9 (52.9)

16 (69.6)

 Right

8 (47.1)

7 (30.4)

 Bilateral

0 (0)

0 (0)

Risk Factors, n, (%)

 Major surgery history

3 (17.6)

5 (21.7)

 Immobilization

2 (11.8)

3 (13.0)

 Hospitalization

2 (11.8)

4 (17.4)

 Recent trauma

4 (23.5)

3 (13.0)

 May–Thurner syndrome

1 (5.9)

4 (17.4)

 Childbirth

1 (5.9)

1 (4.3)

 Malignant disease history

1 (5.9)

3 (13.0)

 Autoimmune diseases

1 (5.9)

2 (8.7)

 Previous DVT or PE

4 (23.5)

3 (13.0)

 Family history of venous thromboembolism

1 (5.9)

2 (8.7)

 Unknown factors

4 (23.5)

4 (17.4)

  1. DVT Deep vein thrombosis, PE Pulmonary embolism
  2. Continuous data are presented as the means ± standard deviations; categorical data are given as the counts (percentage)